Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Laboratorios Richmond S.A.C.I.F.

Market Cap 126B 88.01M 75.92M 69.8M 65.7M 123M 8.31B 124M 827M 322M 4.08B 330M 323M 14.1B P/E 2024
6.08x
P/E 2025 51.6x
Enterprise Value 357B 249M 215M 197M 186M 349M 23.49B 352M 2.34B 911M 11.53B 934M 914M 39.88B EV / Sales 2024
3.04x
EV / Sales 2025 3.08x
Free-Float
17.54%
Yield 2024
1.5%
Yield 2025 -
05-11 Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2026 CI
05-08 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-07 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
11-06 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
08/08/25 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
09/05/25 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
08/05/25 Laboratorios Richmond S.A.C.I.F. announces Annual dividend, payable on May 15, 2025 CI
08/03/25 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
06/11/24 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
13/08/24 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
07/05/24 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
11/03/24 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
10/11/23 Laboratorios Richmond S.A.C.I.F. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
1 day-1.88%
1 week-1.57%
Current month-4.57%
1 month-1.88%
3 months-9.01%
6 months-24.76%
Current year-20.76%
1 week 1,530
Extreme 1530
1,640
1 month 1,520
Extreme 1520
1,725
Current year 1,420
Extreme 1420
2,130
1 year 945
Extreme 945
2,300
3 years 480.5
Extreme 480.5
2,300
5 years 208.5
Extreme 208.5
2,300
10 years 24.8
Extreme 24.8
2,300
Manager TitleAgeSince
President - -
General Counsel - 29/04/2025
Corporate Officer/Principal - 29/04/2025
Director TitleAgeSince
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
Change 5-day change 1-year change 3-year change Capi.($)
-1.88%-1.57%+7.93%+205.07% 88.16M
-0.62%-1.94%+40.83%+146.56% 1,001B
-0.67%-2.09%+53.24%+42.27% 566B
-0.45%-1.52%+19.44%+60.74% 393B
+3.82%+2.29%+24.04%+16.53% 326B
+1.09%+1.65%+26.61%+33.19% 276B
+1.42%+0.06%+26.36%+15.68% 277B
+1.87%+0.87%-41.49%-47.26% 193B
-0.96%+1.95%+18.71%+50.63% 188B
-1.11%+3.74%+16.69%+62.17% 158B
Average -0.25%+0.16%+19.24%+58.56% 337.69B
Weighted average by Cap. -0.26%-0.41%+29.40%+66.22%

Financials

2024 2025
Net sales 91.79B 63.92M 55.15M 50.7M 47.72M 89.67M 6.03B 90.43M 601M 234M 2.96B 240M 235M 10.24B 127B 88.25M 76.13M 69.99M 65.88M 124M 8.33B 125M 829M 323M 4.09B 331M 324M 14.14B
Net income 23.85B 16.61M 14.33M 13.17M 12.4M 23.29M 1.57B 23.49M 156M 60.77M 769M 62.32M 60.99M 2.66B 3.09B 2.15M 1.86M 1.71M 1.61M 3.02M 203M 3.04M 20.21M 7.87M 99.6M 8.07M 7.9M 345M
Net Debt 134B 93.07M 80.29M 73.82M 69.48M 131M 8.78B 132M 875M 341M 4.31B 349M 342M 14.91B 231B 161M 139M 128M 120M 226M 15.18B 228M 1.51B 589M 7.45B 604M 591M 25.78B
Logo Laboratorios Richmond S.A.C.I.F.
Laboratorios Richmond SACIF is an Argentina-based company, which is engaged in the development and manufacture of pharmaceuticals. The Company's product categories include: Antiviral, under the brands Ciganclor, Lazinevir, Leuzan, Mivuten, Probirase, Protease, Selmivir, Trivenz, Virontar, Virontar N, Virontar 600, Vuclodir, Zepril, Zetavudin, and Zetrotax; Oncologi and Oncohematologic, under the brands Bemux, Capecit, Doxetal, Drifen, Espasevit, Fontrax, Gezt, and Monofer, among others; Cardiovascular, under the brands Amze 5, Amze 10, Antiplaq, Bilip 10, Bilip 20, Tacardia, and Timezol 20, among others; Neuropsychiatric, under the brands Dalam 15, Dolofrix 10, Donepes 5, and Prilben 10, among others, as well as Hospital, under the brands Amidiaz, Dalam, and Fentax, among others.
Employees
620
Date Price Change Volume
16/06/26 1,565.00 $ -1.88% 4,012
12/06/26 1,595.00 $ -1.85% 2,362
11/06/26 1,625.00 $ +1.88% 2,208
10/06/26 1,595.00 $ +0.31% 5,402
09/06/26 1,590.00 $ -0.31% 35,894
  1. Stock Market
  2. Stocks
  3. RICH Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!